BDC2.5 mimotope 1040-51 is an effectively agonistic mimotope peptide for the diabetogenic T cell clone BDC2.5, isolated from non-obese diabetic (NOD) mice.
YZ51, a novel potent inhibitor of ribonucleotide reductase (RR), inhibits hepatitis B virus replication by targeting ribonucleotide reductase M2 protein.